Epinephrine HFA-MDI (E004)
API-E004-CL-D2
Phase 3 small_molecule completed
Quick answer
Epinephrine HFA-MDI (E004) for Asthma is a Phase 3 program (small_molecule) at Amphastar Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amphastar Pharmaceuticals
- Indication
- Asthma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed